Cells which express morphological and functional markers originally described in neurons and neural crest: derived endocrine cells are now known to originate from both ectodermal and endodermal progenitors. These cells are organized to secrete peptides, amines, and other regulatory products in response to neurogenic orchemical stimulation. Individual products may function in endocrine, paracrine, neurotransmitter, or neuromodulatory roles. Multiple products are often produced by individual cells and stored in the same secretory granules. The hormonal profiles of particular types of neuroendocrine cells can, to varying degrees, be changed by environmental signals during development or in adult life. These changes are caused both by transcriptional and post-transcriptional mechanisms. Hormonal profiles are also altered during'the development and progression of neoplasia. Signals which stimulate hormone secretion produce a number of ancillary effects, including activation and induction of enzymes which replenish hormone stores, activation of cellular on-. cogenes, and stimulation of cell proliferation. The effects of environmental signals on neuroendocrine cells are mediated by intracellular transduction pathways which involve cyclic AMP, phosphatidylinositol, calcium, and receptor protein kinase activity. These effects can be potentiated, inhibited, or qualitatively altered by exogenous agents.
THE HISTORY OF THE DISPERSED
NEUROENDOCRINE SYSTEM The concept of a neuroendocrine cell, as we now know it, originated from ktudies conducted in the. early to mid-1960s which were aimed at identifying the cell of origin of the newly discovered peptide hormone calcitonin. In the course of those studies, it was shown that calcitonin was produced by parafollicular cells in the thyroid (9, and these cells were renamed C-cells to acknowledge their physiological role.
During these early investigations, A. G. E. Pearse and his co-workers found that C-cells expressed a series of functional markers which were also present in cells of the anterior pituitary and pancreatic islets (58) . These markers included synthesis of polypep-pancreatic islets and numerous sites throughout the airways and gastrointestinal tract (59).
The neural crest hypothesis also triggered numerous embryological investigations aimed at proving or disproving its validity. The most elegant of these employed a quail-chick heterograft technique, in which neural crest or neural tube cells from Japanese quail are grafted into chick embryos which have their own neural crest and other primordia excised (43, 43). The quail cells are characterized by distinctive, target-like nuclei with large central masses of heterochromatin, in contrast to the bland nuclei of the chick cells. These transplanted quail cells migrate normally in their chick hosts, and can then be stained for appropriate peptide hormones and other secretory products.
Using this method, it became clear that the only polypeptide-and amine-producing cells which could be shown to be derived from the neural crest were the adrenal medulla and extra-adrenal paraganglia, the cells of the myenteric plexus and sympathetic ganglia, and the thyroid C-cells (42, 43). Some investigators have recently begun to once again question the neural crest origin of the C-cells on immunohistochemical grounds (32). The grafting data which support such an origin (61) , however, have never been refuted. Exactly 10 yr after the publication of the neural crest hypothesis, Pearse recanted, saying "Considerable volume of evidence has now accumulated which demonstrates beyond doubt that the endocrine cells of the gastro-enteropancreatic axis do not arise from the neural crest" (59) .
After the neural crest hypothesis was disproved, the list of markers shared by neuroendocrine cells in diverse locations continued to expand, and is still expanding. A partial list of new markers includes cell surface markers, constituents of secretory granule matrix and membranes, hormone-synthesizing enzymes, enzymes related to cellular energy metabolism, and cytoskeletal filaments, as summarized in Table I . Some of these markers, such as neuronspecific enolase (68, 69) are pan-neuroendocrine markers which identify virtually all neuroendocrine cells, whereas others, such as specific chromogranin proteins (96), are more cell-type specific. The current concept of a neuroendocrine cell is not a cell which is derived from neuroectoderm. Rather, the term denotes cells which have a shared phenotype characterized by the simultaneous expression of multiple genes encoding a variety of neuronal and endocrine traits. The term "paraneuron" is now used by some investigators to encompass this phenotype
(1 8). In contrast, "APUD cell" has fallen into disuse because some neuroendocrine cells do not have amine-synthesizing ability.
TOXICOLOGIC PATHOLOGY The value of the neural crest hypothesis was not in providing a simple explanation of neuroendocrine embryology, which it failed to do. Instead, the hypothesis was important as a catalyst for a great deal of research which has revolutionized our understanding of neuroendocrine function at the cellular, subcellular and molecular levels. The original paper promulgating the neural crest hypothesis long ago became a citation classic, having been cited over 800 times by 1982 (Curretit Contents, May 10, 1982).
THE ORGANIZATION OF THE

NEUROENDOCRINE SYSTEM
It is now known that identical peptide or amine secretory products are secreted and produced by neuroendocrine cells in different anatomic locations, and that the physiological roles of particular secretory products are dependent upon the anatomical context in which they are released (18). Individual substances can function in endocrine, paracrine, autocrine, neuroendocrine, or neuro-' transmitter modes, depending upon the exact location in which they are produced and the nature of the cells which release them. An additional mode of function may be luminal secretion in the gut, where particular substances released by some cells may act on other cells downstream.
Neuroendocrine cells are multimessenger systems, and as such they are considerably more powerful as transmitters of information than might be anticipated by the traditional and now discarded one-cell, one-messenger hypothesis (29). Peptide hormones are produced in the Golgi apparatus and then packaged into secretory granules. Other granule constituents, for example catecholamines in the case of adrenal chromaffin cells, are produced in the cytoplasm and then taken up into the granules, This means that an individual cell can vary the information content that it transmits under different physiological conditions. One way of accomplishing this is by separately regulating the production of amines, peptides, and other granule constituents (72, 83) . Another is to secrete mature or immature granules which exhibit varying degrees of peptide hormone processing. In addition, the messengers produced and secreted by individual cells may function both locally and at a distance (29). For example, the catecholamines in chromaffin granules are released into the blood stream to act at distant targets. Another constituent of the granule matrix, the ATP, may be broken down immediately upon release to produce adenosine. This substance might then act on adenosine receptors on chromaffin cells themselves to activate tyrosine hydroxylase (1 6), and on blood vessels to increase local blood flow (17).
Secretory granules are complex organelles, which contain more than merely peptides and amines. The most extensively studied granule is that in the adrenal chromaffin cell, which may serve as a general model of neuroendocrine organization (97, 98). Catecholamines are the most abundant constituent of the chromaffin granule,on a molar basis, but they only account for about 20% of the granule weight..
Other constituents include ATP and other nucleotides, chromogranin proteins, neuropeptides, dopamine beta-hydroxylase, peptidases for neuropeptide processing, and ascorbate to act as a co-factor for dopamine beta-hydroxylase or peptide amidation. The widely distributed cholinesterases, initially somewhat puzzling because they could be found in cells not stimulated by acetylcholine, now also appear to have peptide-processing activities (27).
In an adrenal chromaffin cell, tyrosine is converted to dopa and then to dopamine in the cytosol. The dopamine enters the secretory granule to be converted to norepinephrine, which leaves the granule, is converted in the cytosol into epinephrine, and then re-enters the granule. This process is not a typical active transport mechanism. Rather, it is driven by a magnesium ATP-ase in the granule membrane which serves as a proton pump (59, causing the interior of the granule to accumulate protons and have an acidic pH ofabout 5.5. A translocator protein in the granule membrane permits catecholamines to enter the granule in exchange with an efflux of protons (55) . The anti-hypertensive agent reserpine is known to decrease blood pressure by decreasing catecholamine stores. In adult animals, the principal mechanism of action of reserpine and related drugs, such as tetrabenazine, is to bind to the catecholamine translocator protein to inhibit this re-uptake mechanism (9, 35). Secretory granule function is also disrupted by ionophores such as the antibiotic monensin, which causes a Na+ for H+ exchange (60). This agent also interferes with peptide hormone processing in the Golgi apparatus (88).
The ATP in adrenal chromaffin granules plays a well-defined role in maintaining the osmotic strength of the interior of the granule. In an individual chromaffin granule, the catecholamine concentration is approximately 600 millimolar, and in the absence of ATP the granules would undergo osmotic lysis. The ATP forms complexes with the catecholamine molecules in order to maintain an isotonic state (97, 98) . Interestingly, histochemical studies employing the uranaffin reaction (57) suggest that ATP is also present in secretory granules of many, although not all (2), neuroendocrine cells which do not produce catecholamines. Although the role of ATP in these cells is not clear, it might, for example, function only as an autocrine or paracrine modulator acting on purinergic receptors.
Similarly, the proton pump is widely distributed in secretory granules which do not contain catecholamines (8). It has been suggested that the acidic granule interior and the proton gradient may serve to promote uptake of peptide precursors, as well as catecholamines, into certain secretory granules, or to provide an optimal pH for peptide-processing enzymes.
PLASTICITY IN THE NEUROENDOCRINE SYSTEM
Neuroendocrine cells exhibit a fascinating degree of morphological and functional plasticity, both during development and in adult life. They are, to varying degrees, able to change their pattern of hormone expression, their morphology or both, in response to micro-environmental signals. This plasticity might help to explain many of the apparently aberrant characteristics of neuroendocrine cells under pathological conditions. Examples of functional plasticity during development are numerous. These may include shutting off the production of certain hormones or neurotransmitters and replacement by others. For example, migrating neural crest cells have been shown TOXICOLOGIC PATHOLOGY to produce acetylcholine. However, once the cells have reached their destination, they may in some instances cease to produce acetylcholine and begin to produce other neurotransmitters. At later developmental stages, neurons from developing cholinergic ganglia become adrenergic after transplantation to ectopic locations in vivo (42) . Conversely, sympathetic ganglia placed in cell culture may decrease their production of catecholamines and begin to synthesize acetylcholine (42,47). As another example of a classic neurotransmitter switch, immature pancreatic islet cells, in some species, produce catecholamines as well as regulatory peptides. In adult life, the catecholamines are switched off, but the peptide synthesis continues (76) .
In addition to alterations in the phenotype of individual cells, shifts may occur in patterns of hormone production among populations of cells. For example, the developing thyroid in the rat is characterized by large numbers of somatostatin-producing cells, as well as cells which produce calcitonin and calcitonin gene-related product (CGRP). In adult life, there are relatively few somatostatin-producing cells. The calcitonin-CGRP cells persist, but there is an increase in cells which produce cholecystokinin-like (CCK) material (39). Similarly, in the human lung, there are numerous somatostatin-, bornbesin-and CT-CGRP cells during development. In adult life, there seems to be a general decrease in production of all of these peptides. The cells which do remain seem to produce predominantly calci-. tonin and bombesin, but there are fewer bombesin cells than are present during development (90) .
There are 2 principal mechanisms by which changes in secretory products might occur. One is alternative processing of messenger RNA and the other is induction of new messenger RNA. An excellent example of the former involves the calcitonin-CGRP gene. Messenger RNA containing sequences for both calcitonin and CGRP is produced in a variety of cells. However, as a result of cell type-specific splicing machinery, individual cells, whether in the brain, the thyroid or other locations, process this RNA differently to produce either calcitonin or CGRP, or both peptides (65) . The mechanisms which confer intracellular processing specificity are not yet known.
As an example of morphological plasticity, normal neonatal rat chromaffin cells in cell culture, extend axon-like processes and "trans-differentiate" into sympathetic neurons in the presence of nerve growth factor (9 1). This response to NGF is for the most part lost in rat chromaffin cells in adult life under the same culture conditions (13, 86). However, it reappears in rat pheochromocytoma cells (81) :-In contrast to those of the rat, adult human chromaffin cells remain plastic both morphologically and functionally throughout life (72, 82) .
TUMORS OF THE NEUROENDOCRINE SYSTEM
The cells now regarded as parts of the dispersed neuroendocrine system have corresponding tumors. These include medullary thyroid carcinomas, pheochromocytomas and extra adrenal paragangliomas, carcinoids, and poorly differentiated carcinoid-like tumors which are referred to as small cell carcinomas or neuroendocrine carcinomas (2 1). Neuroendocrine tumors to varying degrees express the morphological and functional characteristics of their normal counterparts. They may also express inappropriate characteristics, including those of other endocrine cells and of non-endocrine cells (10, 11, 34, 52, 70, 73).
Several generalizations can be made about the functional characteristics of neuroendocrine tumors (21). First, the tumors express a large number of shared morphological and functional markers, even when they arise in widely separated locations. Second, they are usually multi-hormonal. Any individual neuroendocrine tumor usually can be found to produce at least 2 peptide hormones. Finally, they produce ectopic peptide hormones. These ectopic hormones can be categorized either as developmentally appropriate or developmentally inappropriate. An example of the former is bombesin in human small cell lung cancer. Although many neuroendocrine cells in the adult human airways lose the ability to produce bombesin (go), virtually all cell lines from human small cell lung cancer are characterized by bombesin production (77) . An example of a developmentally inappropriate neuropeptide is vasoactive intestinal peptide in human pheochromocytomas. VIP is normally a marker of nerve cells, but not ofendocrine cells, in adult mammals. However, human pheochromocytomas very frequently produce VIP both in vivo and in viiro (83) .
Like other tumors, but more dramatically so, neuroendocrine tumors are to varying degrees characterized by responsiveness to factors which regulate the growth, differentiation, and function of their normal counterparts. There is considerable evidence that secretory stimuli might be very important in regulating or initiating tumor cell growth. Examples of this phenomenon are C-cell hyperplasia in bulls with excess dietary calcium (38), prolactin-producing pituitary adenomas in rats after' administration of estrogens (1 5), TSH-producing pituitary adenomas in hypophysectomized mice (1 g), growth hormone-producing pituitary tumors in human patients with ectopic sources of GRH (28), gastric G-cell hyperplasia in achlorhydric rats and humans (30), and high altitude human and bovine carotid body tumors (1). Proliferative lesions which arise in the rat adrenal medulla in response to numerous drugs and other forms of stress probably also fall in this category (87) . There is also evidence that environmental signals can alter the hormone or neurotransmitter profile of neuroendocrine tumor cells in vitro (12, 77, 83) . It is, therefore, important to understand the transduction mechanisms normally employed by neuroendocrine cells to interpret and respond to environmental signals, and the ways in which these mechanisms might be altered in response to exogenous agents under normal and pathological conditions.
SIGNAL TRANSDUCTION MECHANISMS IN THE
NEUROENDOCRINE SYSTEM
Neuroendocrine cells secrete hormones and undergo associated changes in response to signals which are both receptor-mediated and non-receptor mediated. The former include neurogenic and hormonal stimuli, and growth factors. Neuroendocrine cells which are subject to neurogenic stimulation are relatively rare, the best examples being adrenal chromaffin. cells and the neuroepithelial bodies in the airways (18). In most other instances, receptormediated stimuli are humoral. Signals which exert their effects by mechanisms which are not receptormediated generally do so by producing "non-specific" metabolic changes. Some substances, such as glucose, may exert either receptor-mediated or metabolic effects in different cell types (53) . It is not clear how some signals, such as changes in concentrations of calcium in the case of thyroid C-cells, or oxygen in the case of the carotid body, are initially received. The signalling events which have so far been most clearly linked to initiation of cell proliferation are receptor-mediated.
The messages received by neuroendocrine cells via interactions ofneurotransmitters or peptide hormones with their receptors are transmitted to the interior of the cells by 3 major transduction pathways. These involve cyclic AMP and protein kinase A (79, phosphatidylinositol and protein kinase C (3, 54), and calcium (6, 63) . In addition, some receptors, such as those for insulin or certain growth factors, have intrinsic protein kinase activity (64) . These pathways regulate cellular functions by phosphorylating and/or binding calcium to such substrates as enzymes, ion channels, DNA-binding proteins, cytoskeletal proteins and secretory vesicles. The calcium effects may themselves be direct, or may be mediated by calmodulin or related calciumbinding proteins (6, 63) .
Although we may speak of separate signal trans-duction pathways and identify ligands which act primarily by one pathway or another, there are in fact' numerous opportunities for cross-communication. This can occur at mahy levels. Ligands which act by one pathway or another can up-regulate (36), down-regulate (33), or otherwise modify (45) receptors for other ligands, or can alter various steps in the intracellular signal transduction mechanisms for other ligands. Protein kinase-A or protein kinase-C can modify calcium channels (49, 94), and calcium can modify the activity of adenylate cyclase, phosphodiesterase, protein kinase C, and phospholipases which initiate phosphoinositol turnover (6, 63) . It is not, therefore, actually possible for any 1 pathway to act in isolation. In a normal cell, multiple signals are received simultaneously, and their balanced effects serve to maintain homeostasis. In pathological states resulting either from abnormal extrinsic signals or from intrinsic or xenobiotic-induced abnormalities in signal transduction, this balance .is disturbed. The result may be not only abnormalities anticipated from the known transduction mechanisms for the particular signals involved, but a complete alteration of the responsiveness to other types of signals which act by other transduction pathways (48).
Most secretion of neuropeptides and amines from normal neuroendocrine cells occurs by calcium-mediated exocytosis. A small amount also occurs by constitutive routes (35, 37) , and the relative proportions ofconstitutive and regulated secretion may be altered in pathological states. The calcium which triggers neuroendocrine secretion may be derived from extracellular fluid, intracellular storage compartments, or both, depending on the specific cell type (49). Extracellular calcium may enter cells through voltage-gated or second messenger-gated channels, or through channels which are intrinsic parts of neurotransmitter receptors (49). The voltage-gated channels are classified as T-(transient), L-(long-acting), or N-type on the basis of their open times, activation thresholds and other characteristics. L-type channels, which are the targets of verapamil, nifedipine and other clinically utilized organic blockers, are the channels principally responsible for regulating intracellular calcium concentrations. T-type channels, in contrast, are believed to be involved principally in initiating action potentials, while N-type channels are hypothesized to play a specialized role in neurotransmitter release (49). Intracellular calcium is mobilized from a poorly-characterized microsomal compartment in re-' sponse to inositol phosphates generated by breakdown of phosphatidylinositol(4, 5) -bis-phosphate (PIP2) in the cell membrane (3, 54).
Many insights into normal and abnormal neu-roendocrine function have been provided by studies utilizing adrenal chromaffin cells as a model, as discussed below (7, 45, 66) . When acetylcholine released from the cholinergic nerve endings which synapse on chromaffin cells interacts with nicotinic cholinergic receptors, the binding of the ligand to the receptor directly opens a receptor ion channel which permits influx of calcium and sodium (45). This influx of ions in the vicinity of the receptor propagates a wave of depolarization spreading from the receptor, leading to the opening of voltage-gated calcium channels and, in some instances, voltage-gated sodium channels. Ifenough channels are opened at once by sufficiently strong stimulation, an action potential may result. Secondary events may later open other calcium channels. Through mechanisms which are not yet clear, calcium reacts with molecules on chromaffin granule membranes and in their vicinity. The granules then migrate to the plasma membrane, fuse with it, and discharge their contents into the circulation. This is a calmodulin-mediated process which can be antagonized by microinjection of antibodies to calmodulin or by phenothiazine-type drugs (66) ..The granule membranes themselves are then recycled.
When acetylcholine reacts with muscarinic acetylcholine receptors on the same cells, a phosphodiesterase known as phospholipase-C cleaves phosphatidylinositol 4,5-bisposphate (PIP2) in the cell membrane to yield inositol-l,4,5-trisphosphate (IP,) plus diacylglycerol in the interior of the cell (3, 45, 54,66). The diacylglycerol activates protein kinase-C, and the IP, mobilizes calcium from intracellular stores (3). Secondary events may then lead to calcium influx from extracellular sources. There are a number ofxenobiotic agents with well-characterized effects on this system. Tumor-promoting phorbol esters are exogenous activators of protein kinase C (5 1). The aminoglycoside antibiotics neomycin, streptomycin, and gentamycin act on mammalian cells to inhibit phospholipases involved in cleavage of PIP and PIP, (93) . Lithium acts to inhibit multiple phosphatases which remove the phosphate groups from IP, in order to recycle the inositol and regenerate the membrane stores of PIP, (3,95). The mechanism of action of lithium as a neuroleptic is thought to involve damping of neurotransmittermediated events that involve inositol 'signalling. Lithium may also increase the expression of certain neuropeptide genes by unknown mechanisms (1 2).
Finally, the cyclic AMP-dependent signal transduction pathway may be activated in chromaffin cells in response to such ligands as VIP (85) , which is present in splanchnic nerve endings in addition to acetylcholine, or to adenosine, which may be an autocrine modulator (16). Receptors for specific li-gands may either be stimulatory or inhibitory. Activation of a stimulatory receptor permits activation of the catalytic subunit-of adenylate cyclase to form cyclic AMP. The latter then activates protein kinase-A. One of the substrates of protein kinase A is tyrosine hydroxylase, which is activated by phosphorylation in order to replenish catecholamine stores (1 6). Alternatively, inhibitory ligands may interact with receptors which inhibit adenylate cyclase.
The extracellular signals which initiate phosphoinositol turnover or cyclic AMP production are coupled to phospholipase-C or adenylate cyclase by G-proteins (5 1 , 75, 95) . These are GTP-binding proteins associated with plasma membrane receptors, which bind GTP when the receptor is occupied by its corresponding ligand, and are subsequently able to stimulate or inhibit the activity of specific cellular enzymes or ion channels. Stimulatory receptors are those which are coupled to stimulatory G-proteins, and inhibitory receptors are those which are coupled to inhibitory G-proteins. There are now known to be multiple stimulatory and inhibitory G-proteins associated with different cell types (5 1). The precise mechanisms which confer specificity in different cells are not yet established. G-proteins generally are heterotrimers, consisting of alpha, beta, and gamma subunits. When a receptor is occupied, the alpha subunit binds GTP and dissociates from beta-gamma which remains intact. The activated alpha unit then interacts with its target, and its activity is subsequently terminated by intrinsic GTPase activity. Interestingly, the oncogenes of the rus family encode proteins which are related to G-proteins, both functionally and structurally, and it has been hypothesized that over-expression of these proteins in cells with abnormal rus expression may contribute to tumor formation. The ras proteins bind GTP but do not bind to beta-gamma or exhibit GTPase activity (5 1). Other oncogene products, for example src and ros, are related to lipases which act in the synthesis or catabolism of PIP, (95) .
The bacterial toxins, cholera toxin and pertussis toxin, have been extensively used to study the functions of G-proteins (5 1 , 75) . Cholera toxin transfers ADP-ribose from NAD to the alpha subunit of the stimulatory G-protein in the cyclic AMP pathway (GJ, thereby increasing activity of adenylate cyclase. Pertussis toxin similarly ADP-ribosylates the alpha subunit of the inhibitory G-protein in the cyclic AMP-dependent pathway (Gi),.and in so doing turns off the inhibitory influences to activate adenylate cyclase by a different mechanism. Other, more recently characterized .G-proteins show variable sensitivities to these toxins (5 1).
It was recently shown that receptor-mediated signals nay activate oncogenes in neuroendocrine cells, ' at SAGE PUBLICATIONS on December 9, 2012 tpx.sagepub.com Downloaded from and that individual oncogenes may be activated by a variety of signals which act via different transduction pathways. For example, c-fos and c-nzyc are transiently expressed in PCI 2 pheochromocytoma cells in response to nerve growth factor, epidermal growth factor, or secretory stimuli such as depolarization or cholinergic stimulation (23, 24). In collaboration with Dr. H. Hofler, we recently have shown that transient activation of c-fos in response to depolarization appears to be a characteristic of many types of neuroendocrine cell lines (31). It is intriguing to speculate that sustained or repeated activation of a specific oncogene such as c-fos might be a final common path by which signals which stimulate hormone secretion by different types of normal neuroendocrine cells also stimulate cell proliferation to meet increased physiological demand.
On the other side of the coin, abnormal oncogene activation in neoplastic neuroendocrine cells can affect responses to other types of growth-regulating signals. A case in point is the overexpression of nzyc by PC12 pheochromocytoma cells. PC12 cells are rounded cells which resemble normal chromaffin cells until they are treated with nerve growth factor. NGF causes typical PC12 cells to extend arborizing processes similar to those of sympathetic neurons, to become electrically excitable and to cease dividing (25, 26). However, when PC12 cells are made to artificially and continuously express abnormally high levels of nzyc by transfection with the oncogene linked to an inappropriate promotor, NGF becomes mitogenic rather than antimitogenic (48). This is a very interesting observation in view of the fact that N-nzyc is frequently amplified in human neuroblastomas (4), which do not show growth arrest in response to NGF (74) . These kinds of studies of normal and pathological interactions between different signal transduction mechinisms are now being conducted extensively, but are essentially still in their' infancy. Hopefully, they will continue to shed light on regulation of neuroendocrine cell function and differentiation in both normal and pathological states. ' . tober: 364-368.
371-398.
Secretory Vesicles. New York Acad. Science, New York. 
Jumblatt
